HAYWARD, Calif., May 10, 2022--(BUSINESS WIRE)--Mawi DNA Technologies (Mawi), a medical device company focusing on the development of innovative technologies for biosampling, has launched the NextSWAB™, a 100% medical-grade plastic swab designed and manufactured in the US. Mawi launched this new product in response to the COVID-19 swab shortage. It is designed for high efficiency collection without the possibility of contamination from glue or fibers used in flock and cotton swabs that may inhibit PCR based assays. NextSWAB™ is currently optimized for nasal sample collection with validation for other sample types ongoing.
"The NextSWAB™ sterile sampling applicator is six inches in length with a unique head design positioned at the distal end," said Dr. Bassam El-Fahmawi, CEO of Mawi. "The swab head has two channels separated by a septum that retains the collected nasal material which can then be released into the transport media with a gentle shake. The flexible head fits into crevices with ease and effectiveness. It enables anterior nasal sample collection with minimal user discomfort sufficient for a meaningful result," Dr. El-Fahmawi added.
The NextSWAB™ is compatible with many sample transport tubes making it ideal for multiple swab sample pooling in a single tube. However, to achieve optimal results, it is most effective when used in conjunction with Mawi’s iSWAB-Microbiome-EL sample collection technology which allows users to skip the RNA extraction step in COVID-19 molecular tests. A second nasal sample can be added to the same tube creating a more concentrated sample to improve overall reliability of the test. The NextSWAB™ comes ready for use and does not require any preparation for specimen collection.
"Our NextSWAB™ fully releases its contents into the sample transport media removing the need for the swab to be transported with the sample," Dr. El-Fahmawi pointed out. "A fully concentrated liquid sample can then be quickly processed with robotic liquid handling systems or any laboratory workflow. During initial R&D testing, the unique and patent pending head design has shown higher collection efficiency for nasal (mid-turbinate and anterior nares) samples than flocked swabs," he said.
With demand for COVID-19 sample collection swabs, the supply chain line for the NextSWAB™ is reliable and stable thanks to the plastic molded construction and USA based manufacturing. For more information on the NextSWAB™, visit www.mawidna.com.
Mawi DNA Technologies, founded in 2013, has developed and commercialized the iSWAB technology, an innovative system for collection of biosamples. Mawi’s mission is to uphold sample integrity from anywhere in the world at room temperature, enabling true sample diversity across any geography or population segment. At Mawi, The Future of Biosampling is Here™. For more information, visit http://www.mawidna.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510005587/en/
Investors: Jerome David, VP of Sales and Marketing 510-256-5186, j.david@mawidna.com
Media Contact: Susan Tellem, APR, RN, BSN 310-313-3444, text or call 310-613-3504 susan@tellemgrodypr.com
As a lot of you folks know, I’m a numbers guy. I let my advanced market quantitative systems guide me in my recommendations. And I’ve learned to spot the warning signs when trouble is brewing. Today, I want to share 10 stocks that my quantitative system recently flagged as immediate sells. Take a look below; some of these names might surprise you. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ticker Company Name Total Grade AMZN Amazon.com, Inc. D DIS Walt Disney Company D GOOG
The company posted weak results and saw a dramatic fall in its share price over 2022
Time flies. But it also crashes.
Quantum computing has been a hot topic recently as scientists and investors look to harness this groundbreaking technology’s power. One promising avenue in this area is the field of quantum computing stocks. They are rapidly gaining popularity among investors looking for high-potential opportunities. These stocks offer access to cutting-edge research and developments in the rapidly growing world of quantum computing. At the same time, they offer lucrative returns in the years ahead for risk-tole
The social-media giant’s planned cuts are expected to affect many thousands of its workforce, which exceeded 87,000 as of September.
(Bloomberg) -- The private market is coming to collect -- and it threatens to wreak havoc across global stocks and bonds. Most Read from BloombergTwitter Now Asks Some Fired Workers to Please Come BackUkraine Latest: US and Russia Discussed Containing War, WSJ SaysHouston Mogul’s $75 Million Win on Astros Hits Caesars HardestPutin’s Ukraine War Is Entering a Terrifying New PhaseMethane Cloud Spotted by Satellite Near India Waste SiteAs financial conditions tighten around the world, private-marke
The Bureau of Labor Statistics will report the October Consumer Price Index on Thursday. Economists expect an 8% increase in CPI year over year.
The CEO of the EV maker has been focused for several weeks on the social network Twitter, his new acquisition.
In this video, I will talk about why shares of Twilio (NYSE: TWLO) plunged 35% after the company reported Q3 earnings, and whether investors should see this as an opportunity or a warning. For the full insights, watch the video, consider subscribing, and click the special offer link below.
Apple iPhone 14 Pro production has been hit by China Covid curbs. Meta Platforms is expected to announce big job cuts.
Seesaw trading and mixed messages – that’s been the market’s pattern for the past few weeks, and last week was no exception. The week started with four straight days losses, but ended on a winning Friday session after an unexpectedly strong jobs report. Even so, the S&P 500 was down 3.35% for the week, snapping a four week rally. Overall, the index is down 21% for the year, in bear territory, and losses on the tech-heavy NASDAQ are even steeper, at 33%. The conflicting currents make it difficult
Buffett highly recommends owning S&P 500 index funds. And he practices what he preaches with these two.
Shares of Amazon.com (NASDAQ: AMZN) plunged 12% this past week, according to data from S&P Global Market Intelligence, furthering the decline in the online retail giant's stock price since its third-quarter earnings report on Oct. 27. Amazon's net sales grew by 15% year over year to $127.1 billion. Excluding foreign exchange movements, the e-commerce leader's revenue was up 19%.
A fresh government inflation reading and U.S. midterm elections are the most highly anticipated events on Wall Street’s radar this week.
The online used car retailer fell almost 39% in one session on Wall Street, after disastrous quarterly results.
The stock market can play tricks on your mind. It's been a long fall for many growth stocks in 2022, but keep your head up. Stocks like Shopify (NYSE: SHOP), Workday (NASDAQ: WDAY), and Sea Limited (NYSE: SE) were losers in 2022, but here's why they could be big winners in 2023 and beyond.
Hundreds of Chinese companies are listed on U.S. markets. But which are the best Chinese stocks to buy or watch right now? Among the best are Nio, Baidu, Li Auto, Pinduoduo and BYD Co.. China is the world's most-populous nation and the second-largest economy, with a booming urban middle class and amazing entrepreneurial activity.
Before you open a retirement account, you should know the disadvantages of Roth IRAs, including income limits. Learn about the drawbacks of Roth IRAs.
Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Tesla Inc. recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.
Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?